Blakely T, Salmond C, Tobias M
Communicable Disease Centre, Porirua.
N Z Med J. 1998 Apr 24;111(1064):142-4.
To estimate the population hepatitis B surface antigen (HBsAg) carrier prevalence for adults in New Zealand.
Data for 1987 from the New Zealand Police Department and New Zealand Customs Department hepatitis B sero-marker survey were further analysed. The sample size was 5510 staff who had completed a questionnaire, had blood sera taken and were not already immunised against hepatitis B.
Maori adults had a HBsAg carrier prevalence of 5.43% (95% confidence interval 3.07-8.81), Pacific adults 4.44% (1.65-9.42), and European adults 0.42% (0.26-0.65). Other ethnic minorities and people with two or more self-assigned ethnic identities had a carrier prevalence of 3.85% (1.06-9.56). There were non-significant differences in this study for carrier prevalence by sex, age and region.
Policy formation on screening programmes for hepatitis B carriers should assume a HBsAg carrier prevalence of about 5% for Maori, Pacific people and ethnic minorities, and about 0.5% for New Zealanders of European extraction.
评估新西兰成年人中乙肝表面抗原(HBsAg)携带者的流行率。
对来自新西兰警察局和新西兰海关乙肝血清标志物调查的1987年数据进行进一步分析。样本量为5510名工作人员,他们完成了问卷调查、采集了血清且尚未接种乙肝疫苗。
毛利成年人的HBsAg携带者流行率为5.43%(95%置信区间3.07 - 8.81),太平洋岛民成年人为4.44%(1.65 - 9.42),欧洲成年人为0.42%(0.26 - 0.65)。其他少数族裔以及具有两种或更多自我认定种族身份的人群携带者流行率为3.85%(1.06 - 9.56)。本研究中,携带者流行率在性别、年龄和地区方面无显著差异。
关于乙肝携带者筛查项目的政策制定应假定,毛利人、太平洋岛民和少数族裔的HBsAg携带者流行率约为5%,欧洲裔新西兰人的流行率约为0.5%。